Eye on Innovation
neuromodulation
- Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn™, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms
- A Randomized Controlled Study of Remote Computerized Cognitive, Neurofeedback, and Combined Training in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
- Clinical Trial to Test Wearable Device as Treatment for Chronic Pain, Opioid Withdrawal
- New Technology Helps Recovery From Opioid Addiction
- FDA Grants Breakthrough Designation to Magnus’ Neurostimulation Technology
- Brain Implants Could Fight Opioid Addiction
- Houston Med-Tech Companies Partner on Wearable Device for Opioid Withdrawal
- First-Of-Its-Kind Brain Chip to Treat Mental Disorders Being Developed at the U of M
- BrainsWay Receives FDA Clearance for Smoking Addiction in Adults